Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gustave Roussy, Cancer Campus, Grand Paris
With
National Cancer Institute, France
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women who have had a recent diagnosis of atypical breast lesions (atypical metaplasia, atypical ductal hyperplasia, atypical lobular hyperplasia, lobular carcinoma in situ) on a breast biopsy for microcalcifications on mammography Or for little suspect distortion in ultrasound or mammary MRI.
Report of the anatomopathological examination of the biopsy allowing the diagnosis of an atypical lesion available
Patient 18 years or more
Informed consent signed.
Patient affiliated to a system of social security or beneficiary of such plan
General condition ECOG-OMS 0 or 1
You may not be if
Nodular lesion associated with ultrasound or mammography opacity
Palpable nodule
Presence of ductal carcinoma in situ or invasive carcinoma associated to biopsy
Personal history of breast cancer or homo contralateral
Previous history of breast irradiation or breast cancer or other area for malignancy (Hodgkin, etc ...)
Women with a BRCA1 or BRCA2 mutation diagnosed or other genetic predisposition to breast cancer and highly penetrant autosomal dominant.
Pregnant or nursing women
Women with a cons-indication or refusal of surgery
Private Women of freedom under guardianship.
Presence of aggressive lobular in situ carcinoma (pléioforme, Florida or necrosis)
Clareo Health | Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions
